Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.

Annals of internal medicine·2026
Same author

Impact of low levels of arsenic in drinking water with incident urologic cancers in Washington state.

Journal of hazardous materials·2026
Same author

A systematic comparison of cavitation regimes and histotripsy efficiency across pulse duration and repetition rate in a fibrous tissue mimicking phantom.

Research square·2026
Same author

The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.

BJU international·2026
Same author

The clinical utility of prostate MRI before biopsy.

Nature reviews. Urology·2026
Same author

Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer.

Neoplasia (New York, N.Y.)·2026

Related Experiment Video

Updated: Mar 19, 2026

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.4K

Extreme Gleason Upgrading From Biopsy to Radical Prostatectomy: A Population-based Analysis.

Brian R Winters1, Jonathan L Wright2, Sarah K Holt1

  • 1Department of Urology, University of Washington School of Medicine, Seattle, WA.

Urology
|June 18, 2016
PubMed
Summary

Gleason upgrading at radical prostatectomy (RP) is common, with extreme upgrading occurring in a significant portion of patients. Risk factors like age and PSA levels influence upgrading odds.

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.8K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.3K

Related Experiment Videos

Last Updated: Mar 19, 2026

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.8K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.3K

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • Gleason score is critical for prostate cancer prognosis.
  • Gleason upgrading at radical prostatectomy (RP) can alter treatment and management.
  • Understanding risk factors for upgrading is essential for patient counseling.

Purpose of the Study:

  • To identify risk factors associated with extreme Gleason upgrading at RP.
  • To analyze the incidence and predictors of Gleason score changes from biopsy to RP.

Main Methods:

  • Utilized a large, population-based cancer registry (Surveillance, Epidemiologic, and End Results database, 2010-2011).
  • Included patients diagnosed with Gleason 3+3 or 3+4 on prostate needle biopsy.
  • Employed multivariate logistic regression to evaluate clinicopathologic factors and upgrading odds.

Main Results:

  • 34% of patients experienced upgrading; extreme upgrading occurred in 6% of Gleason 3+3 and 4% of Gleason 3+4 cases.
  • Age, clinical stage, diagnostic PSA, and % positive biopsy cores predicted upgrading.
  • Higher PSA and >50% core positivity increased odds of extreme upgrading in Gleason 3+3.
  • Higher PSA and palpable disease predicted extreme upgrading in Gleason 3+4.
  • Positive surgical margins were significantly higher in patients with extreme upgrading.

Conclusions:

  • Gleason upgrading at RP is a frequent event in a large population-based cohort.
  • Extreme Gleason upgrading occurs in a clinically significant proportion of patients.
  • Identifying patients at risk for upgrading can inform clinical decision-making and surgical planning.